UB Paderborn / Katalog / Suche / in CDI

Comparability of selected assays on the new cobas pro integrated solutions cobas ISE neo and cobas C 703 analytical units under routine-like conditions

Clinica chimica acta, 2024-05, Vol.558, p.118657, Article 118657

2024

Volltextzugriff (PDF)

Beta‐cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA‐DQ types in type 1 diabetes

Clinical and experimental immunology, 2001-11, Vol.126 (2), p.236-241

2001

Volltextzugriff (PDF)

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA10501-DQB10301 haplotype in Type 1 diabetes mellitus

Diabetic medicine, 2000-08, Vol.17 (8), p.618-622

2000

Volltextzugriff (PDF)

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age

Diabetes care, 2000-06, Vol.23 (6), p.838-844

2000

Volltextzugriff (PDF)

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry

Diabetes care, 2000-08, Vol.23 (8), p.1072-1078

2000

Volltextzugriff (PDF)

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry

Diabetes care, 2000-06, Vol.23 (6), p.838-844

2000

Volltextzugriff (PDF)

CTLA‐4 gene polymorphism confers susceptibility to insulin‐dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers

Clinical and experimental immunology, 2003-10, Vol.110 (1), p.98-103

2003

Volltextzugriff (PDF)

Correlation between GABA release from rat islet beta -cells and their metabolic state

American journal of physiology: endocrinology and metabolism, 2002-04, Vol.282 (4), p.E937-E942

2002

Volltextzugriff (PDF)

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset

Diabetes care, 2000-08, Vol.23 (8), p.1072-1078

2000

Volltextzugriff (PDF)

The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status

The journal of clinical endocrinology and metabolism, 2001-09, Vol.86 (9), p.4358-4363

2001

Volltextzugriff (PDF)

Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies

Diabetes care, 2001-07, Vol.24 (7), p.1181-1186

2001

Volltextzugriff (PDF)

Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus : A registry-based study

Pancreas, 1998, Vol.16 (1), p.50-59

1998

Volltextzugriff (PDF)

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA10501-DQB10301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry

Diabetic medicine, 2000-08, Vol.17 (8), p.618-622

2000

Volltextzugriff (PDF)

CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry

Clinical and experimental immunology, 1997-10, Vol.110 (1), p.98-103

1997

Volltextzugriff (PDF)

Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus: a registry-based study. The Belgian Diabetes Registry

Pancreas, 1998-01, Vol.16 (1), p.50-59

1998

Volltextzugriff (PDF)

CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers

Clinical and experimental immunology, 1997-10, Vol.110 (1), p.98-103

1997

Volltextzugriff (PDF)

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non‐invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration

HIV medicine, 2014-01, Vol.15 (1), p.30-39

2014

Volltextzugriff (PDF)

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

Clinical infectious diseases, 2015-07, Vol.61 (1), p.40-48

2015

Volltextzugriff (PDF)

Epidemiology of liver disease in cystic fibrosis: a longitudinal study

Journal of hepatology, 2004-12, Vol.41 (6), p.920-925

2004

Volltextzugriff (PDF)

Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Antibodies to Hepatitis B Core Antigen: Aquitaine Cohort, 2002–2003

Clinical infectious diseases, 2005-03, Vol.40 (5), p.750-753

2005

Volltextzugriff (PDF)

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)‐coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]

HIV medicine, 2016-11, Vol.17 (10), p.758-765

2016

Volltextzugriff (PDF)

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study

Journal of hepatology, 2014-01, Vol.60 (1), p.46-53

2014

Volltextzugriff (PDF)

Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician

Drug and alcohol dependence, 2011-07, Vol.116 (1), p.228-232

2011

Volltextzugriff (PDF)

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients

Journal of viral hepatitis, 2011-07, Vol.18 (7), p.e307-e314

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Comparability of selected assays on the new cobas pro integrated solutions cobas ISE neo and cobas C 703 analytical units under routine-like conditions

Beta‐cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA‐DQ types in type 1 diabetes

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA10501-DQB10301 haplotype in Type 1 diabetes mellitus

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry

CTLA‐4 gene polymorphism confers susceptibility to insulin‐dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers

Correlation between GABA release from rat islet beta -cells and their metabolic state

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset

The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status

Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies

Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus : A registry-based study

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA10501-DQB10301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry

CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry

Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus: a registry-based study. The Belgian Diabetes Registry

CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non‐invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010

Epidemiology of liver disease in cystic fibrosis: a longitudinal study

Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Antibodies to Hepatitis B Core Antigen: Aquitaine Cohort, 2002–2003

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)‐coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study

Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients

Suchergebnisse filtern